- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Big Green Snowflakes
Swedish Pharmaceuticals & Biotech Big Green Snowflakes
Results
101
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
101 companies
BioGaia
Market Cap: SEK 10.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 103.40
7D
-0.7%
1Y
-12.0%
Camurus
Market Cap: SEK 43.5b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 731.50
7D
1.0%
1Y
6.6%
Bonesupport Holding
Market Cap: SEK 20.0b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 304.40
7D
-4.4%
1Y
-2.7%
Saniona
Market Cap: SEK 1.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 11.90
7D
-10.3%
1Y
152.9%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 23.15
7D
0.7%
1Y
1.3%
Swedish Orphan Biovitrum
Market Cap: SEK 93.8b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 269.80
7D
-2.3%
1Y
-17.4%
Biovica International
Market Cap: SEK 173.4m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.63
7D
-0.3%
1Y
-77.1%
Lärkberget
Market Cap: SEK 50.3m
Operates as an investment company.
LARK
SEK 2.54
7D
-1.6%
1Y
1.6%
Mendus
Market Cap: SEK 400.0m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 7.68
7D
9.7%
1Y
-2.4%
Elicera Therapeutics
Market Cap: SEK 312.6m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 6.44
7D
-7.6%
1Y
279.9%
Ascelia Pharma
Market Cap: SEK 457.1m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.94
7D
-8.9%
1Y
92.7%
Vitrolife
Market Cap: SEK 18.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 135.20
7D
-1.5%
1Y
-45.4%
Xbrane Biopharma
Market Cap: SEK 634.4m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.25
7D
-5.3%
1Y
74.5%
Moberg Pharma
Market Cap: SEK 420.2m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.94
7D
-0.7%
1Y
-20.4%
AlzeCure Pharma
Market Cap: SEK 339.0m
Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.95
7D
-16.4%
1Y
47.9%
Active Biotech
Market Cap: SEK 209.6m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.17
7D
2.7%
1Y
-57.0%
Egetis Therapeutics
Market Cap: SEK 1.8b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 4.98
7D
-3.8%
1Y
-1.3%
BioArctic
Market Cap: SEK 24.0b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 270.40
7D
-6.8%
1Y
54.0%
Cantargia
Market Cap: SEK 656.3m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 2.64
7D
3.7%
1Y
-30.5%
AcouSort
Market Cap: SEK 70.1m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 3.31
7D
5.1%
1Y
-76.4%
Lipigon Pharmaceuticals
Market Cap: SEK 96.3m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.16
7D
-7.8%
1Y
-36.4%
Sprint Bioscience
Market Cap: SEK 64.6m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.61
7D
0.3%
1Y
-50.2%
Guard Therapeutics International
Market Cap: SEK 443.7m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 22.00
7D
-3.5%
1Y
-25.7%
BioInvent International
Market Cap: SEK 1.9b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 29.25
7D
2.6%
1Y
-32.1%
SynAct Pharma
Market Cap: SEK 1.0b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 18.88
7D
-0.7%
1Y
114.4%
Corline Biomedical
Market Cap: SEK 355.1m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 14.50
7D
-3.3%
1Y
79.0%
Medivir
Market Cap: SEK 213.8m
A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.
MVIR
SEK 1.91
7D
-0.3%
1Y
-45.5%
Abera Bioscience
Market Cap: SEK 124.4m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 8.10
7D
-2.4%
1Y
93.8%
Nanologica
Market Cap: SEK 102.5m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 1.16
7D
-6.5%
1Y
-51.7%
Annexin Pharmaceuticals
Market Cap: SEK 194.8m
A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 27.60
7D
0%
1Y
-52.4%
Xspray Pharma
Market Cap: SEK 1.8b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 47.60
7D
-1.3%
1Y
1.3%
Vicore Pharma Holding
Market Cap: SEK 2.6b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 11.08
7D
-8.4%
1Y
54.7%
Curasight
Market Cap: DKK 246.8m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 5.38
7D
-3.2%
1Y
-46.5%
Alligator Bioscience
Market Cap: SEK 146.9m
A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.
ATORX
SEK 4.22
7D
0.5%
1Y
-99.7%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 140.7m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.57
7D
-13.3%
1Y
-22.7%
NextCell Pharma
Market Cap: SEK 119.6m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 1.07
7D
-0.4%
1Y
-26.9%